Certificate under Regulation 74 (5) of SEBI (DP) Regulation, 2018 for the quarter ended on 30th June, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genomic Valley Biotech Ltd has submitted the Regulation 74(5) certificate for the quarter ended 30th June 2025, as required by SEBI's Depositories and Participants Regulations. The certificate was issued by Beetal Financial & Computer Services Pvt Ltd, the company's Registrar and Share Transfer Agent (RTA). It confirms that all securities received from Depository Participants for dematerialization during the quarter were duly processed and confirmed to the depositories. The certificate also confirms that physical share certificates received for demat have been mutilated, cancelled after verification, and the depository's name has been substituted as the registered owner in the company's records within the stipulated 15-day timeline.
This is a routine quarterly compliance filing with no material impact on the company's operations, financials, or stock price. It simply reaffirms that the company's share dematerialization processes are functioning normally and in line with SEBI norms.